Showing results (1601-1610 of 1,626) with videos related to

Sort By:
Pageof 163
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2013
Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial stagingLin-Quan Tang, Qiu-Yan Chen, Wei Fan, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2017
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trialSu-Mei Cao, Qi Yang, Ling Guo, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 2, 2025
Dynamic postoperative prognosis and follow-up optimization for gastric cancer patients after neoadjuvant therapy: a multicenter retrospective studyQing Zhong, Zhi-Quan Zhang, Kai-Ning Ye, et al.
European Journal of Cancer (Oxford, England : 1990)|August 20, 2019
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trialQi Yang, Su-Mei Cao, Ling Guo, et al.
Journal of Hepatology|December 31, 2019
Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinomaLiang-Qing Dong, Li-Hua Peng, Li-Jie Ma, et al.
Asian Journal of Andrology|May 1, 2015
Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(-1)Rui Chen, Li-Qun Zhou, Xiao-Bing Cai, et al.
NEJM Evidence|April 22, 2025
Induction versus Concurrent Chemotherapy for Advanced Nasopharyngeal CarcinomaPei-Yu Huang, Xu-Yin Chen, Xi Ding, et al.
BMJ (Clinical Research Ed.)|February 10, 2026
Standard chemoradiotherapy with concurrent and adjuvant camrelizumab in patients with high risk nasopharyngeal carcinoma: multicentre, randomised, open label, phase 3 trialRui You, Gui-Qiong Xu, Xi Ding, et al.
Global Change Biology|March 19, 2013
Spatial patterns and climate drivers of carbon fluxes in terrestrial ecosystems of ChinaGui-Rui Yu, Xian-Jin Zhu, Yu-Ling Fu, et al.
JAMA Oncology|July 24, 2020
Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical TrialRui You, You-Ping Liu, Pei-Yu Huang, et al.
Pageof 163